SRZNW Insider Trading - Surrozen, Inc.

所有內部人士

內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。

如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。

內部人士買入淨數（排名）

N/A

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示（範圍從0到100%）。

內部人士買入佔流通股比例（排名）

N/A

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數，除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Surrozen, Inc. - Equity Warrant內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。

See our leaderboard of most profitable insider traders.

內部人士	持股數量	分拆調整
Mitchell J Md Blutt 10% Owner - [10%]	0	0
Anna Berkenblit Director - [D]	35,129	2,342
Christopher Y Chai Director - [D]	35,129	2,342
Column Group Iii Gp, Lp 10% Owner - [10%]	1,361,485	1,361,485
Column Group Iii, Lp 10% Owner - [10%]	4,904,884	1,361,485
Column Group Iii-a, Lp 10% Owner - [10%]	4,904,884	1,361,485
Consonance Capital Management LP Director, 10% Owner - [D] [10%]	450,828	0
Consonance Capital Opportunity Fund Management LP Director - [D]	0	128,900
Consonance Capman GP, LLC Director - [D]	450,828	0

內部人士	持股數量	分拆調整
Consonance Life Sciences 10% Owner - [10%]	1,885,000	0
Mary Haak-Frendscho Director - [D]	35,129	2,342
Christopher Haqq -	30,000	2,000
Joshua Cory House	0
Jennifer Jarrett -	30,000	2,000
Tim Kutzkey Director, 10% Owner - [D] [10%]	1,361,485	1,361,485
Yang Li Exec. Vice President, Research - [O]	17,216	17,216
Shao-Lee Lin Director - [D]	35,129	2,342
Kevin Harold Livingston 10% Owner - [10%]	1,885,000	0

內部人士	持股數量	分拆調整
Craig C Parker Chief Executive Officer, Director - [D] [O]	16,553	16,553
Mace Rothenberg Director - [D]	35,129	2,342
Donald J Santel -	30,000	2,000
Benny Soffer 10% Owner - [10%]	1,885,000	0
Gad Soffer	0
TCG Crossover GP II, LLC 10% Owner - [10%]	736,547	736,547
Geertrui Vanhove Chief Medical Officer - [O]	32,412	2,161
David J Woodhouse Director - [D]	35,129	2,342
Charles O Williams Chief Operating Officer - [O]	16,571	16,571
Wen-Chen Yeh Chief Scientific Officer - [O]	27,216	1,814

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分，我們分析了在 SRZNW / Surrozen, Inc. - Equity Warrant 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格	最高淨利 ($)	最高回報率（%）
2026-03-24	TCG Crossover GP II, LLC	53,329	24.6931	53,329	24.6931	1,316,858	43	34.1300	503,261	38.22
2026-03-24	TCG Crossover GP II, LLC	53,329	24.6931	53,329	24.6931	1,316,858
2026-03-23	TCG Crossover GP II, LLC	7,611	24.8999	7,611	24.8999	189,513
2026-03-23	TCG Crossover GP II, LLC	7,612	24.8999	7,612	24.8999	189,538
2026-03-16	TCG Crossover GP II, LLC	595	24.9857	595	24.9857	14,866
2026-03-16	TCG Crossover GP II, LLC	595	24.9857	595	24.9857	14,866
2026-03-13	TCG Crossover GP II, LLC	17,716	24.8769	17,716	24.8769	440,719
2026-03-13	TCG Crossover GP II, LLC	17,717	24.8769	17,717	24.8769	440,744
2026-03-12	TCG Crossover GP II, LLC	6,187	24.9851	6,187	24.9851	154,583

經調整價格已按拆股調整。經調整股數已按拆股調整。

SRZNW / Surrozen, Inc. - Equity Warrant Insider Trades

追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分，我們分析了在 SRZNW / Surrozen, Inc. - Equity Warrant 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
2026-05-04	Williams Charles O	2,036	33.3328	2,036	33.3328	67,866	29	23.1450	-20,742	-30.56
2026-05-04	Parker Craig C	4,524	33.3328	4,524	33.3328	150,798
2026-05-04	Li Yang	1,584	33.3328	1,584	33.3328	52,799
2026-01-05	Li Yang	1,118	19.8652	1,118	19.8652	22,209
2026-01-05	Williams Charles O	1,566	19.8652	1,566	19.8652	31,109
2025-01-03	Williams Charles O	1,181	17.3700	1,181	17.3700	20,514
2025-01-03	Li Yang	843	17.3700	843	17.3700	14,643
2022-12-14	BLUTT MITCHELL J MD	1,748,750		116,583
2022-12-14	BLUTT MITCHELL J MD	1,297,922		86,528

經調整價格已按拆股調整。經調整股數已按拆股調整。

交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。

呈報日期	交易日期	表格	內部人士	證券代碼	證券種類	代碼	直接	行使價格	單位價格	股數變化	價值變化 (1K)	剩餘期權	剩餘股份
2026-05-05	2026-05-04	4	Li Yang	SRZN	Common Stock	S - Sale	D		33.3328	-1,584	-53		17,216
2026-05-05	2026-05-01	4	Li Yang	SRZN	Common Stock	M - Exercise	D			4,375			18,800
2026-05-05	2026-05-04	4	Williams Charles O	SRZN	Common Stock	S - Sale	D		33.3328	-2,036	-68		16,571
2026-05-05	2026-05-01	4	Williams Charles O	SRZN	Common Stock	M - Exercise	D			5,625			18,607
2026-05-05	2026-05-04	4	Parker Craig C	SRZN	Common Stock	S - Sale	D		33.3328	-4,524	-151		16,553
2026-05-05	2026-05-01	4	Parker Craig C	SRZN	Common Stock	M - Exercise	D			12,500			21,077
2026-04-01	2026-03-31	4	Li Yang	SRZN	Common Stock	G - Gift	D			-1,666			14,425
2026-03-25	2026-03-24	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.6931	53,329	1,317		736,547
2026-03-25	2026-03-24	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.6931	53,329	1,317		736,554
2026-03-25	2026-03-23	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.8999	7,611	190		683,218
2026-03-25	2026-03-23	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.8999	7,612	190		683,225
2026-03-16	2026-03-16	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.9857	595	15		675,610
2026-03-16	2026-03-16	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.9857	595	15		675,613
2026-03-16	2026-03-13	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.8769	17,716	441		675,015
2026-03-16	2026-03-13	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.8769	17,717	441		675,018
2026-03-16	2026-03-12	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.9851	6,187	155		657,299
2026-03-16	2026-03-12	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.9851	6,187	155		657,301
2026-02-13	2026-02-12	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		23.8625	546	13		651,112
2026-02-13	2026-02-12	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		23.8625	547	13		651,114
2026-02-13	2026-02-11	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		23.5750	8,881	209		650,563
2026-02-13	2026-02-11	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		23.5750	8,882	209		650,567
2026-02-03	2026-02-03	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.9400	2,177	48		641,682
2026-02-03	2026-02-03	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.9400	2,178	48		641,685
2026-02-03	2026-02-02	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.3800	365	8		639,505
2026-02-03	2026-02-02	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.3800	366	8		639,507
2026-02-03	2026-01-30	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.3900	2,135	46		639,140
2026-02-03	2026-01-30	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.3900	2,136	46		639,141
2026-01-28		3	TCG Crossover GP II, LLC	SRZN	Common Stock		I						637,005
2026-01-28		3	TCG Crossover GP II, LLC	SRZN	Common Stock		I						637,005
2026-01-20	2026-01-20	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.5999	9,568	188		1,016,658
2026-01-20	2026-01-20	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.5999	8,484	166		900,292
2026-01-20	2026-01-16	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		20.0000	1,358	27		1,007,090
2026-01-20	2026-01-16	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		20.0000	1,204	24		891,808
2026-01-20	2026-01-15	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8890	6,303	125		1,005,732
2026-01-20	2026-01-15	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8890	5,590	111		890,604
2026-01-20	2026-01-20	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.5999	9,568	188		1,016,658
2026-01-20	2026-01-20	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.5999	8,484	166		900,292
2026-01-20	2026-01-16	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		20.0000	1,358	27		1,007,090
2026-01-20	2026-01-16	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		20.0000	1,204	24		891,808
2026-01-20	2026-01-15	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8890	6,303	125		1,005,732
2026-01-20	2026-01-15	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8890	5,590	111		890,604
2026-01-15	2026-01-14	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.9883	2,927	59		999,429
2026-01-15	2026-01-14	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.9883	2,596	52		885,014
2026-01-15	2026-01-13	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8041	6,609	131		996,502
2026-01-15	2026-01-13	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8041	5,861	116		882,418
2026-01-15	2026-01-14	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.9883	2,927	59		999,429
2026-01-15	2026-01-14	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.9883	2,596	52		885,014
2026-01-15	2026-01-13	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8041	6,609	131		996,502
2026-01-15	2026-01-13	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8041	5,861	116		882,418
2026-01-08	2026-01-06	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8872	8,003	159		989,893
2026-01-08	2026-01-06	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8872	7,097	141		876,557
2026-01-08	2026-01-06	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8872	8,003	159		989,893
2026-01-08	2026-01-06	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8872	7,097	141		876,557
2026-01-06	2026-01-05	4	Li Yang	SRZN	Common Stock	S - Sale	D		19.8652	-1,118	-22		16,091
2026-01-06	2026-01-02	4	Li Yang	SRZN	Common Stock	M - Exercise	D			2,500			17,209
2026-01-06	2026-01-05	4	Williams Charles O	SRZN	Common Stock	S - Sale	D		19.8652	-1,566	-31		12,982
2026-01-06	2026-01-02	4	Williams Charles O	SRZN	Common Stock	M - Exercise	D			3,500			14,548
2025-12-16	2025-12-15	4	Li Yang	SRZN	Common Stock	A - Award	D		8.1100	1,666	14		14,709
2025-12-16	2025-12-15	4	Williams Charles O	SRZN	Common Stock	A - Award	D		8.1100	1,666	14		11,048
2025-12-16	2025-12-15	4	Parker Craig C	SRZN	Common Stock	A - Award	D		8.1100	1,553	13		8,577
2025-12-08	2025-12-05	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.5409	16,381	320		981,890
2025-12-08	2025-12-05	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.5409	14,503	283		869,460
2025-12-08	2025-12-04	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		17.3470	2,791	48		965,509
2025-12-08	2025-12-04	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		17.3470	2,475	43		854,957
2025-12-08	2025-12-05	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.5409	16,381	320		981,890
2025-12-08	2025-12-05	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.5409	14,503	283		869,460
2025-12-08	2025-12-04	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		17.3470	2,791	48		965,509
2025-12-08	2025-12-04	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		17.3470	2,475	43		854,957
2025-12-02	2025-11-13	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		12.6500	167,307	2,116		962,718
2025-12-02	2025-11-13	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		12.6500	148,150	1,874		852,482
2025-11-17	2025-11-13	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		12.6500	167,307	2,116		962,718
2025-11-17	2025-11-13	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		12.6500	148,150	1,874		852,482
2025-06-16	2025-06-13	4	Li Yang	SRZN	Common Stock	A - Award	D		8.0600	400	3		13,043
2025-06-16	2025-06-13	4	Williams Charles O	SRZN	Common Stock	A - Award	D		8.0600	400	3		9,382
2025-06-16	2025-06-13	4	Parker Craig C	SRZN	Common Stock	A - Award	D		8.0600	400	3		7,024
2025-03-28		3	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock		I						795,411
2025-03-28		3	Kutzkey Tim By The Column Group Opportunity III, LP	SRZN	Common Stock		I						344,827
2025-03-28		3	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock		I						704,332
2025-03-28	2025-03-26	4	COLUMN GROUP III GP, LP By The Column Group Opportunity III, LP	SRZN	Common Stock	P - Purchase	I		11.6000	344,827	4,000		344,827
2025-03-28	2025-03-26	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		11.6000	365,769	4,243		795,411
2025-03-28	2025-03-26	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		11.6000	323,886	3,757		704,332
2025-01-06	2025-01-03	4	Li Yang	SRZN	Common Stock	S - Sale	D		17.3700	-843	-15		13,345
2025-01-06	2025-01-02	4	Li Yang	SRZN	Common Stock	M - Exercise	D			2,500			14,188
2025-01-06	2025-01-03	4	Williams Charles O	SRZN	Common Stock	S - Sale	D		17.3700	-1,181	-21		8,982
2025-01-06	2025-01-02	4	Williams Charles O	SRZN	Common Stock	M - Exercise	D			3,500			10,163
2024-06-18	2024-06-14	4	Li Yang	SRZN	Common Stock	A - Award	D		5.6700	400	2		10,888
2024-06-18	2024-06-14	4	Williams Charles O	SRZN	Common Stock	A - Award	D		5.6700	400	2		5,863
2024-06-18	2024-06-14	4	Parker Craig C	SRZN	Common Stock	A - Award	D		5.6700	400	2		5,824
2024-04-17	2024-04-04	4/A	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		15.5000	102,651	1,591		326,992
2024-04-17	2024-04-04	4/A	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		15.5000	90,897	1,409		289,549
2024-04-17	2024-04-04	4/A	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		15.5000	102,651	1,591		326,992
2024-04-17	2024-04-04	4/A	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		15.5000	90,897	1,409		289,549
2024-04-08	2024-04-04	4	Williams Charles O	SRZN	Common Stock	P - Purchase	D			1,474			1,474
2024-04-08	2024-04-04	4	Parker Craig C	SRZN	Common Stock	P - Purchase	D			1,474			1,474
2024-04-08	2024-04-04	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		15.5000	102,651	1,591		332,885
2024-04-08	2024-04-04	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		15.5000	90,897	1,409		294,767
2024-04-08	2024-04-04	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		15.5000	102,651	1,591		332,885
2024-04-08	2024-04-04	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		15.5000	90,897	1,409		294,767
2023-12-18	2023-12-15	4	Williams Charles O	SRZN	Common Stock	A - Award	D		5.6700	2,085	12		2,085
2023-12-18	2023-12-15	4	Li Yang	SRZN	Common Stock	A - Award	D		5.6700	2,085	12		2,085
2023-12-18	2023-12-15	4	Parker Craig C	SRZN	Common Stock	A - Award	D		5.6700	2,046	12		2,046
2023-08-23		3	Li Yang	SRZN	Common Stock		I						10,538
2023-08-23		3	Li Yang	SRZN	Common Stock		D						121,524
2023-06-20	2023-06-15	4	Yeh Wen-Chen	SRZN	Common Stock	A - Award	D		0.3800	17,638	7		27,216
2023-06-20	2023-06-15	4	Parker Craig C	SRZN	Common Stock	A - Award	D		0.3800	25,000	10		34,578
2023-06-20	2023-06-15	4	Williams Charles O	SRZN	Common Stock	A - Award	D		0.3800	25,000	10		34,578
2022-12-19	2022-12-15	4	Yeh Wen-Chen	SRZN	Common Stock	A - Award	D		0.4100	9,578	4		229,138
2022-12-19	2022-12-15	4	Parker Craig C	SRZN	Common Stock	A - Award	D		0.4100	9,578	4		9,578
2022-12-19	2022-12-15	4	Vanhove Geertrui	SRZN	Common Stock	A - Award	D		0.4100	9,578	4		32,412
2022-12-19	2022-12-15	4	Williams Charles O	SRZN	Common Stock	A - Award	D		0.4100	9,578	4		9,578
2022-12-15	2022-12-14	4	BLUTT MITCHELL J MD By Consonance Life Sciences, LLC	SRZN	Common Stock	S - Sale	I			-1,885,000			0
2022-12-15	2022-12-14	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Common Stock	S - Sale	I			-450,827			0
2022-12-15	2022-12-14	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Common Stock	S - Sale	I			-1,297,922			0
2022-12-15	2022-12-14	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Common Stock	S - Sale	I			-1,748,750			0
2022-03-03	2022-03-01	4	Yeh Wen-Chen	SRZN	Option (right to buy)	A - Award	D	3.11		125,000		125,000
2022-03-03	2022-03-01	4	Parker Craig C	SRZN	Stock Option (right to buy)	A - Award	D	3.11		370,000		370,000
2022-03-03	2022-03-01	4	Williams Charles O	SRZN	Option (right to buy)	A - Award	D	3.11		125,000		125,000
2022-03-03	2022-03-01	4	Vanhove Geertrui	SRZN	Option Grant (right to buy)	A - Award	D	3.11	3.1100	125,000	389	125,000
2021-08-16		3	COLUMN GROUP III, LP By The Column Group III, LP	SRZN	Common Stock		I						4,343,245
2021-08-16		3	COLUMN GROUP III, LP By The Column Group III-A, LP	SRZN	Common Stock		I						4,904,884
2021-08-16		3	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock		I						4,343,245
2021-08-16		3	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock		I						4,904,884
2021-08-16	2021-08-12	4	Parker Craig C	SRZN	Stock Option (right to buy)	A - Award	D	10.25		183,335		183,335
2021-08-16	2021-08-12	4	Vanhove Geertrui	SRZN	Employee Stock Option (right to buy)	A - Award	D	10.25		36,647		36,647
2021-08-16		3	Vanhove Geertrui	SRZN	Common Stock		D						22,834
2021-08-16	2021-08-12	4	Williams Charles O	SRZN	Employee Stock Option (right to buy)	A - Award	D	10.25		14,597		14,597
2021-08-16		3	WOODHOUSE DAVID J	SRZN	Common Stock		D						35,129
2021-08-16		3	Rothenberg Mace	SRZN	Common Stock		D						35,129
2021-08-16		3	Haak-Frendscho Mary	SRZN	Common Stock		D						35,129
2021-08-16		3	Berkenblit Anna	SRZN	Common Stock		D						35,129
2021-08-16		3	Lin Shao-Lee	SRZN	Common Stock		D						35,129
2021-08-16		3	Yeh Wen-Chen	SRZN	Common Stock		D						219,560
2021-08-16		3	CHAI CHRISTOPHER Y	SRZN	Common Stock		D						35,129
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Warrants	A - Award	I	11.50		-144,667		144,667
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Warrants	D - Sale to Issuer	I	11.50		-144,667		0
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Common Stock	A - Award	I			1,451,000			1,885,000
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Common Stock	A - Award	I			434,000			434,000
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Class B Ordinary Shares	D - Sale to Issuer	I			-1,451,000			0
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Class B Ordinary Shares	J - Other	I			-759,000			1,451,000
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-434,000			0
2021-08-13	2021-08-11	4	Jarrett Jennifer	SRZN	Class B Ordinary Shares	D - Sale to Issuer	D			-30,000		0
2021-08-13	2021-08-11	4	Jarrett Jennifer	SRZN	Common Stock	A - Award	D			30,000			30,000
2021-08-13	2021-08-11	4	Santel Donald J	SRZN	Class B Ordinary Shares	D - Sale to Issuer	D			-30,000		0
2021-08-13	2021-08-11	4	Santel Donald J	SRZN	Common Stock	A - Award	D			30,000			30,000
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Warrants	A - Award	I	11.50		-144,667		144,667
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Warrants	D - Sale to Issuer	I	11.50		-144,667		0
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Common Stock	A - Award	I			1,451,000			1,885,000
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Common Stock	A - Award	I			434,000			434,000
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Class B Ordinary Shares	D - Sale to Issuer	I			-1,451,000			0
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Class B Ordinary Shares	J - Other	I			-759,000			1,451,000
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-434,000			0
2021-08-13	2021-08-11	4	Haqq Christopher	SRZN	Class B Ordinary Shares	D - Sale to Issuer	D			-30,000		0
2021-08-13	2021-08-11	4	Haqq Christopher	SRZN	Common Stock	A - Award	D			30,000			30,000
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Warrants	A - Award	I	11.50		-144,667		144,667
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Warrants	D - Sale to Issuer	I	11.50		-144,667		0
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Common Stock	A - Award	I			1,451,000			1,885,000
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Common Stock	A - Award	I			434,000			434,000
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Class B Ordinary Shares	D - Sale to Issuer	I			-1,451,000			0
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Class B Ordinary Shares	J - Other	I			-759,000			1,451,000
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-434,000			0
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Warrants (right to buy)	A - Award	I	11.50		107,309		150,275
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Warrants (right to buy)	A - Award	I	11.50		308,940		432,640
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Warrants (right to buy)	A - Award	I	11.50		416,250		582,917
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Warrants (right to buy)	P - Purchase	I	11.50		42,966		42,966
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Warrants (right to buy)	P - Purchase	I	11.50		123,700		123,700
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Warrants (right to buy)	P - Purchase	I	11.50		166,667		166,667
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Common Stock	A - Award	I			321,928			450,828
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Common Stock	A - Award	I			926,822			1,297,922
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Common Stock	A - Award	I			1,248,750			1,748,750
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Common Stock	A - Award	I			128,900			128,900
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-128,900			0
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Common Stock	A - Award	I			371,100			371,100
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-371,100			0
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Common Stock	A - Award	I			500,000			500,000
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-500,000			0
2021-05-19	2020-11-23	4/A	Consonance Life Sciences	CHFW	Warrant	A - Award	D	11.50		136,667		136,667
2021-05-19	2020-11-23	4/A	Consonance Life Sciences	CHFW	Class A Ordinary Shares	A - Award	D			410,000			410,000
2021-05-19	2020-11-18	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	S - Sale	D		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	S - Sale	D		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	S - Sale	D		0.0109	-30,000	-0		2,240,000
2021-05-19	2020-11-10	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	D - Sale to Issuer	D			-575,000			2,300,000
2021-05-19	2020-10-08	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	D - Sale to Issuer	D			-718,750			2,875,000
2021-05-19	2020-09-04	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	A - Award	D		0.0070	3,593,750	25		3,593,750
2021-05-19	2020-12-01	4/A	Soffer Benny	CHFW	Warrant	A - Award	I	11.50		8,000		144,667
2021-05-19	2020-12-01	4/A	Soffer Benny	CHFW	Class A Ordinary Shares	A - Award	I			24,000			434,000
2021-05-19	2020-11-23	4/A	BLUTT MITCHELL J MD	CHFW	Warrant	A - Award	I	11.50		136,667		136,667
2021-05-19	2020-11-23	4/A	BLUTT MITCHELL J MD	CHFW	Class A Ordinary Shares	A - Award	I			410,000			410,000
2021-05-19	2020-11-18	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,240,000
2021-05-19	2020-11-10	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-575,000			2,300,000
2021-05-19	2020-10-08	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-718,750			2,875,000
2021-05-19	2020-09-04	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	A - Award	I		0.0070	3,593,750	25		3,593,750
2021-05-19	2020-11-23	4/A	Soffer Benny	CHFW	Warrant	A - Award	I	11.50		136,667		136,667
2021-05-19	2020-11-23	4/A	Soffer Benny	CHFW	Class A Ordinary Shares	A - Award	I			410,000			410,000
2021-05-19	2020-11-18	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,240,000
2021-05-19	2020-11-10	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-575,000			2,300,000
2021-05-19	2020-10-08	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-718,750			2,875,000
2021-05-19	2020-09-04	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	A - Award	I		0.0070	3,593,750	25		3,593,750
2021-05-19	2020-12-01	4/A	Consonance Life Sciences	CHFW	Warrant	A - Award	D	11.50		8,000		144,667
2021-05-19	2020-12-01	4/A	Consonance Life Sciences	CHFW	Class A Ordinary Shares	A - Award	D			24,000			434,000
2021-05-19	2020-12-01	4/A	Livingston Kevin Harold	CHFW	Warrant	A - Award	I	11.50		8,000		144,667
2021-05-19	2020-12-01	4/A	Livingston Kevin Harold	CHFW	Class A Ordinary Shares	A - Award	I			24,000			434,000
2021-05-19	2020-11-23	4/A	Livingston Kevin Harold	CHFW	Warrant	A - Award	I	11.50		136,667		136,667
2021-05-19	2020-11-23	4/A	Livingston Kevin Harold	CHFW	Class A Ordinary Shares	A - Award	I			410,000			410,000
2021-05-19	2020-11-18	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,240,000
2021-05-19	2020-11-10	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-575,000			2,300,000
2021-05-19	2020-10-08	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-718,750			2,875,000
2021-05-19	2020-09-04	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	A - Award	I		0.0070	3,593,750	25		3,593,750
2021-05-19	2020-12-01	4/A	BLUTT MITCHELL J MD	CHFW	Warrant	A - Award	I	11.50		8,000		144,667
2021-05-19	2020-12-01	4/A	BLUTT MITCHELL J MD	CHFW	Class A Ordinary Shares	A - Award	I			24,000			434,000
2021-05-19		3/A	BLUTT MITCHELL J MD Consonance Life Sciences, LLC	CHFW	Class B Ordinary Shares		I						2,210,000
2021-05-19		3/A	Soffer Benny Consonance Life Sciences, LLC	CHFW	Class B Ordinary Shares		I						2,210,000
2021-05-19		3/A	Livingston Kevin Harold Consonance Life Sciences, LLC	CHFW	Class B Ordinary Shares		I						2,210,000
2021-05-19		3/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares		D						2,210,000
2020-12-04	2020-11-23	4	BLUTT MITCHELL J MD By Managed Account	CHFW	Class A Ordinary Shares	P - Purchase	I			128,900			128,900
2020-12-04	2020-11-23	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	CHFW	Class A Ordinary Shares	P - Purchase	I			371,100			371,100
2020-12-04	2020-11-23	4	BLUTT MITCHELL J MD By Consonance Capital Master Account, LP	CHFW	Class A Ordinary Shares	P - Purchase	I			500,000			500,000
2020-12-03	2020-12-01	4	Livingston Kevin Harold	CHFW	Warrant	P - Purchase	I	11.50		8,000		144,667
2020-12-03	2020-12-01	4	Livingston Kevin Harold	CHFW	Class A Ordinary Shares	P - Purchase	I			24,000			434,000
2020-12-03	2020-12-01	4	Consonance Life Sciences	CHFW	Warrant	P - Purchase	D	11.50		8,000		144,667
2020-12-03	2020-12-01	4	Consonance Life Sciences	CHFW	Class A Ordinary Shares	P - Purchase	D			24,000			434,000
2020-12-03	2020-12-01	4	Soffer Benny	CHFW	Warrant	P - Purchase	I	11.50		8,000		144,667
2020-12-03	2020-12-01	4	Soffer Benny	CHFW	Class A Ordinary Shares	P - Purchase	I			24,000			434,000
2020-12-03	2020-12-01	4	BLUTT MITCHELL J MD	CHFW	Warrant	P - Purchase	I	11.50		8,000		144,667
2020-12-03	2020-12-01	4	BLUTT MITCHELL J MD	CHFW	Class A Ordinary Shares	P - Purchase	I			24,000			434,000
2020-11-25	2020-11-23	4	Consonance Life Sciences	CHFW	Warrant	P - Purchase	D	11.50		136,667		136,667
2020-11-25	2020-11-23	4	Consonance Life Sciences	CHFW	Class A Ordinary Shares	P - Purchase	D			410,000			410,000
2020-11-25	2020-11-23	4	Soffer Benny	CHFW	Warrant	P - Purchase	I	11.50		136,667		136,667
2020-11-25	2020-11-23	4	Soffer Benny	CHFW	Class A Ordinary Shares	P - Purchase	I			410,000			410,000
2020-11-25	2020-11-23	4	BLUTT MITCHELL J MD	CHFW	Warrant	P - Purchase	I	11.50		136,667		136,667
2020-11-25	2020-11-23	4	BLUTT MITCHELL J MD	CHFW	Class A Ordinary Shares	P - Purchase	I			410,000			410,000
2020-11-25	2020-11-23	4	Livingston Kevin Harold	CHFW	Warrant	P - Purchase	I	11.50		136,667		136,667
2020-11-25	2020-11-23	4	Livingston Kevin Harold	CHFW	Class A Ordinary Shares	P - Purchase	I			410,000			410,000

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）

SRZNW / Surrozen, Inc. - Equity Warrant - Insider Trading and Ownership Report - SEC Form 3, 4, 5